Combined hepatitis A and B vaccine: Providing a bright future for preventing hepatitis

Expert Opinion on Biological Therapy

Volumn 9, Issue 9, 2009, Pages 1235-1240

  Hewlett, Alex T ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Hepatitis A; Hepatitis B; Immunogenicity; Twinrix; Vaccine

Indexed keywords

HB VAX PRO; HEPATITIS A HEPATITIS B VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; RECOMBINANT HEPATITIS B VACCINE; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; AUTOIMMUNE HEPATITIS; CLINICAL TRIAL; DRUG EFFICACY; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; ERYTHEMA MULTIFORME; FATIGUE; GASTROINTESTINAL SYMPTOM; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOGENICITY; INJECTION SITE REACTION; NAUSEA; NONHUMAN; REVIEW; SEROCONVERSION; SKIN REDNESS; UNSPECIFIED SIDE EFFECT; VACCINATION;

HEPATITIS A ANTIBODIES; HEPATITIS A VACCINES; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; VACCINES, COMBINED;

EID: 68949101391     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712590903160639     Document Type: Review

References (28)

1. Center for disease control and prevention. Disease burden from viral hepatitis A, B, and C in the United States. Available from: http://www.cdc.gov/ hepatitis/Statistics.htm. [Last accessed 6 July 2009]
2. Vento S, Garofano T, Renzini C, et al. Fulminant hepatitis associated with hepatitis A virus super-infection in patients with chronic C. N Engl J Med 1998;338:286-290 (Pubitemid 28065254)
3. Keefe EB. Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases? Am J Gastroenterol 1995;90:201-205
4. Feray C, Gigou M. et al. Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis. Gastroenterology 1993;104:549-555 (Pubitemid 23033429)
5. Modlin JF, Snider DE, Clover RD, et al. Centers for disease control and prevention. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1999;48(RR-12):1-37
6. Katz SL, Montage JL, Hardegree C, et al. Centers for disease control and prevention. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1991;40(RR-13):1-19
7. Mahoney FJ, Kane M. Hepatitis B vaccine. In: Plotkin SA, Orenstein WA, editors, Vaccines, 3rd edition. Philadelphia: WB Saunders, 1999. p. 650-671
8. Twinri® US prescribing information. Philadelphia (PA): GlaxoSmithKline Biologicals, April 2007
9. Ambrosch F, Wiedermann G, Andre FE, et al. Clinical and immunological investigation of a new combined hepatitis A and hepatitis B vaccine. J Med Virol 1994;44:452-456
10. Thoelen S, Van Damme P, Leentvaar-Kuypers A, et al. The first combined vaccine against hepatitis A and B: an overview. Vaccine 1999;17:1657-1662 (Pubitemid 29138897)
11. Joines R, Blatter M, Abraham B, et al. A prospective, randomized, comparative US trial of a combination hepatitis A and B vaccine (Twinrix) with corresponding monovalent vaccines (Havrix and Engerix-B) in adults. Vaccine 2001;19:4710-4719 (Pubitemid 32800755)
12. Knoll A, Hottentrager B, Kainz J, et al. Immunogenicity of a combined hepatitis A and B vaccine in healthy young adults. Vaccine 2000;18:2029-2032 (Pubitemid 30114347)
13. Van Herck K, Leroux-Roels G, Van Damme P, et al. Ten-year antibody persistence induced by hepatitis A and B vaccine (Twinrix) in adults. Travel Med Infect Dis 2007;5(3):171-175 (Pubitemid 46585955)
14. Diaz-Mitoma F, Law B, Subramanya A, Hoet B. Long term antibody persistence induced by a combined hepatitis A and B vaccine in children and adolescents. Vaccine 2008;26:1759-1763
15. Van der Wielen M, Van Damme P, Chlibek R, et al. Hepatitis A/B vaccination of adults over 40 years old: comparison of three vaccine regimens and effect of influencing factors. Vaccine 2006;24:5509-5515 (Pubitemid 43831382)
16. Cardell K, Akerlind B, Sallberg M, Fryden A. Excellent response rate to a double dose of combined hepatitis A and B vaccine in previous nonresponders to hepatitis B vaccine. J Infect Dis 2008;198(3):299-304
17. Villano SA, Nelson KE, Vlahov D, et al. Hepatitis A among homosexual men and injection drug users: more evidence for vaccination. Clin Infect Dis 1997;25:726-728 (Pubitemid 27392619)
18. Lugoboni F, Quaglio G, Pajusco B, et al. Immunogenicity, reactogenicity and adherence to a combined hepatitis A and B vaccine in illict drug users. Addiction 2004;99:1560-1564 (Pubitemid 39664831)
19. Rogers N, Lubman DI. An accelerated hepatitis B vaccination schedule for young drug users. Aust NZ J Public Health 2002;5:324-326
20. Jacobs JR, Gibson GA, Meyerhoff AS. Cost-effectiveness of hepatitis A and B vaccine for healthcare and public safety workers in the western United States. Infect Control Hosp Epidemiol 2004;25:563-569
21. Keystone JS. Travel-related hepatitis B: risk factors and prevention using an accelerated vaccination schedule. Am J Med 2005;118:63-8S
22. Nothdurft HD, Dietrich M, Zuckerman JN, et al. A new accelerated vaccination schedule for rapid protection against hepatitis A and B. Vaccine 2002;20:1157-1162 (Pubitemid 34135952)
23. Nothdurft HD, Zuckerman J, Stoffel M, et al. Accelerated vaccination schedules provide protection against hepatitis A and B in last minute travelers. J Travel Med 2004;11:260-261 (Pubitemid 39062183)
24. Ramonet M, Reverbel da Silveira T, Lisker-Melman M, et al. A two-dose combined vaccine against hepatitis A and B in healthy children and adolescents compared to the corresponding monovalent vaccines. Arch Med Res 2002;33:67-73 (Pubitemid 34092272)
25. Kaur S, Handa S. Erythema multiforme following vaccination in an infant. Indian J Dermatol Venereol Leprol 2008;74:251-253 (Pubitemid 351918882)
26. Csepregi A, Treiber G, Rocken C, Malfertheiner P. Acute exacerbation of autoimmune hepatitis induced by Twinrix. World J Gastroenterol 2005;11:4114-4116 (Pubitemid 41235614)
27. Van Damme P, Leroux-Roels G, Law B, et al. Long-term persistence of antibodies induced by vaccination and safety follow up, with the first combined vaccine against hepatitis A and B in children and adults. J Med Virol 2001;65:6-13
28. Sjogren MH. Prevention of hepatitis in nonresponders to initial hepatitis B virus vaccination. Am J Med 2005;118(Suppl 10A):34S-39S